Literature DB >> 23949827

Dementia and mild cognitive impairment in adults with intellectual disability: issues of diagnosis.

Sharon J Krinsky-McHale1, Wayne Silverman.   

Abstract

Individuals with intellectual disability (ID) are now living longer with the majority of individuals reaching middle and even "old age." As a consequence of this extended longevity they are vulnerable to the same age-associated health problems as elderly adults in the general population without ID. This includes dementia, a general term referring to a variety of diseases and conditions causing substantial loss of cognitive ability and functional declines; adults with Down syndrome are at especially high risk. A great deal of recent effort has focused on the very earliest detectable indicators of decline (and even prodromal stages of dementia-causing diseases). A condition called mild cognitive impairment (MCI) has been conceptually defined as a decline in functioning that is more severe than expected with typical brain aging but not severe enough to meet criteria for a diagnosis of dementia. Consensus criteria for both dementia and MCI have been developed for typically developing adults but are of limited applicability for adults with ID, given their pre-existing cognitive impairments. Early diagnosis will continue to be of growing importance, both to support symptomatic treatment and to prevent irreversible neuropathology when interventions are developed to slow or halt the progression of underlying disease. While the intellectual and developmental disabilities field has for some time recognized the need to develop best-practices for the diagnosis of MCI and dementia, there remains a pressing need for empirically based assessment methods and classification criteria.
Copyright © 2013 Wiley Periodicals, Inc., a Wiley company.

Entities:  

Keywords:  Alzheimer's disease; Down syndrome; aging; dementia; intellectual disability; mild cognitive impairment

Mesh:

Year:  2013        PMID: 23949827     DOI: 10.1002/ddrr.1126

Source DB:  PubMed          Journal:  Dev Disabil Res Rev        ISSN: 1940-5529


  29 in total

Review 1.  Cerebrovascular contributions to aging and Alzheimer's disease in Down syndrome.

Authors:  Donna M Wilcock; Frederick A Schmitt; Elizabeth Head
Journal:  Biochim Biophys Acta       Date:  2015-11-26

2.  Rapid assessment of cognitive function in down syndrome across intellectual level and dementia status.

Authors:  D M Walsh; E Doran; W Silverman; A Tournay; N Movsesyan; I T Lott
Journal:  J Intellect Disabil Res       Date:  2015-05-29

3.  Telomere shortening in Down syndrome patients--when does it start?

Authors:  Aleksandra Gruszecka; Przemysław Kopczyński; Dorota Cudziło; Natalia Lipińska; Aleksandra Romaniuk; Wojciech Barczak; Natalia Rozwadowska; Ewa Totoń; Błażej Rubiś
Journal:  DNA Cell Biol       Date:  2015-03-18       Impact factor: 3.311

4.  Is Apolipoprotein E4 an Important Risk Factor for Dementia in Persons with Down Syndrome?

Authors:  Troy T Rohn; Katie L McCarty; Julia E Love; Elizabeth Head
Journal:  J Parkinsons Dis Alzheimers Dis       Date:  2014-12-08

5.  Outcome Measures for Clinical Trials in Down Syndrome.

Authors:  Anna J Esbensen; Stephen R Hooper; Deborah Fidler; Sigan L Hartley; Jamie Edgin; Xavier Liogier d'Ardhuy; George Capone; Frances A Conners; Carolyn B Mervis; Leonard Abbeduto; Michael Rafii; Sharon J Krinsky-McHale; Tiina Urv
Journal:  Am J Intellect Dev Disabil       Date:  2017-05

Review 6.  Exosomal biomarkers in Down syndrome and Alzheimer's disease.

Authors:  Eric D Hamlett; Aurélie Ledreux; Huntington Potter; Heidi J Chial; David Patterson; Joaquin M Espinosa; Brianne M Bettcher; Ann-Charlotte Granholm
Journal:  Free Radic Biol Med       Date:  2017-09-05       Impact factor: 7.376

7.  Laxative use among older adults with intellectual disability: a cross-sectional observational study.

Authors:  Hadiah AlMutairi; Máire O'Dwyer; Elish Burke; Mary McCarron; Philip McCallion; Martin C Henman
Journal:  Int J Clin Pharm       Date:  2019-12-02

8.  Intellectual Disability, Mild Cognitive Impairment, and Risk for Dementia.

Authors:  Wayne P Silverman; Warren B Zigman; Sharon J Krinsky-McHale; Robert Ryan; Nicole Schupf
Journal:  J Policy Pract Intellect Disabil       Date:  2013-09-01

9.  Evaluation of the National Task Group-Early Detection Screen for Dementia: Sensitivity to 'mild cognitive impairment' in adults with Down syndrome.

Authors:  Wayne Silverman; Sharon J Krinsky-McHale; Florence Lai; H Diana Rosas; Christy Hom; Eric Doran; Margaret Pulsifer; Ira Lott; Nicole Schupf
Journal:  J Appl Res Intellect Disabil       Date:  2020-12-13

10.  Building the Future Therapies for Down Syndrome: The Third International Conference of the T21 Research Society.

Authors:  Mara Dierssen; Yann Herault; Pablo Helguera; Maria Martínez de Lagran; Anna Vazquez; Bradley Christian; Maria Carmona-Iragui; Frances Wiseman; William Mobley; Elizabeth M C Fisher; Veronique Brault; Anna Esbensen; Lisa M Jacola; Marie Claude Potier; Eric D Hamlett; Leonard Abbeduto; Laura Del Hoyo Soriano; Jorge Busciglio; Maria Florencia Iulita; John Crispino; Sébastien Malinge; Eugenio Barone; Marzia Perluigi; Floriana Costanzo; Jean Maurice Delabar; Renata Bartesaghi; Alain D Dekker; Peter De Deyn; Juan Fortea Ormaechea; Patricia A Shaw; Tarik F Haydar; Stephanie L Sherman; André Strydom; Anita Bhattacharyya
Journal:  Mol Syndromol       Date:  2021-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.